Cerebrolysin in the treatment of brain injuries of moderate severity

Talypov, A.E.; Myachin, M.Y.; Kuksova, N.S.; Kordonsky, A.Y.

Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 98-106

2014


ISSN/ISBN: 1997-7298
PMID: 25591645
Document Number: 674973
To assess the efficacy of cerebrolysin in patients with cranial/brain injury of moderate severity. The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity. Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity. The drug was well-tolerated.

Document emailed within 1 workday
Secure & encrypted payments